GLP-1 uptake by country will continue to diverge along these lines for the foreseeable future, shaped by the interplay of healthcare financing, regulatory sequencing, and the pace at which national health systems formally recognise obesity as a chronic disease requiring structured, long-term pharmacological management
Gastrointestinal (GI) Effects The most common side effects reported in the TRIUMPH trials include: Nausea: Reported by ~45% of users, primarily during dose escalation
This precision neurology approach, leveraging the unique insights from circRNA, is critical to facilitating early diagnosis and treatment for Alzheimers. Trontinemab, a disease-modifying drug designed to rapidly clear amyloid plaques from the brain, is moving ahead into Phase III trials
Grains: Brown rice, whole-wheat pasta, oats, and quinoa